| Literature DB >> 9273472 |
S Paterna1, A Pinto, A Arrostuto, M G Cannavò, P Di Pasquale, C Cottone, G Licata.
Abstract
After considering the clinical and physiopathological aspects of Raynaud's phenomenon, the authors have evaluated the medium effects of therazosine in 2 groups of patients, respectively with idiopathic and secondary Raynaud's phenomenon. The results show that the therazosin determines a decrease of number, intensity and duration of vasospastic attacks to the hands as well as an improvement of telethermographic and ultrasonographic findings.Entities:
Mesh：
Substances：
Year: 1997 PMID： 9273472
Source DB: PubMed Journal: Minerva Cardioangiol ISSN： 0026-4725 Impact factor: 1.347